Results 171 to 180 of about 9,376,530 (330)
Distribution of JC Virus DNA in Peripheral Blood Lymphocytes of Hematological Disease Cases.
N Shimizu +12 more
openalex +2 more sources
Minimal Residual Disease in Hematological Malignancies [PDF]
Pia Raanani, Andreas Hochhaus
openalex +1 more source
Nanographene oxide (NGO) attenuates graft‐versus‐host disease (GVHD) severity by inhibiting STAT1‐mediated M1 macrophage polarization and suppressing T‐cell activation. NGO‐primed macrophages (NGO‐Mac) further enhance regulatory T‐cell induction via IL‐10. Both NGO and NGO‐Mac therapies mitigate inflammation and immune pathology, offering cell‐free and
Aaron Yu +18 more
wiley +1 more source
Cord-Blood Engraftment Using an Enhanced Dual-Conditioning Regimen for Malignant Hematologic Diseases. [PDF]
Ding J +6 more
europepmc +1 more source
Preliminary Studies of Serum Acute-Phase Protein Concentrations in Hematologic and Neoplastic Diseases of the Dog [PDF]
Fernando Tecles +4 more
openalex +1 more source
Norepinephrine/α2B‐adrenoceptor axis promotes the secretion of Notch2 intracellular domain (N2ICD)‐enriched extracellular vesicles (EVs) from macrophages. These EVs deliver N2ICD into fibroblasts, thereby inducing their activation. Deletion of Notch2 or α2B‐AR in macrophages disrupts N2ICD‐enriched EV formation and alleviates kidney fibrosis in mice ...
Huiwen Ren +14 more
wiley +1 more source
A comprehensive evaluation of plasma metagenomics sequencing for the diagnosis of suspected infection in pediatric patients with hematologic diseases. [PDF]
Zhang S, Guo Q, Gai W, Guo Y, Zheng Y.
europepmc +1 more source
Clinical, Biochemical, and Hematological Characteristics, Disease Prevalence, and Prognosis of Dogs Presenting with Neutrophil Cytoplasmic Toxicity [PDF]
Itamar Aroch, Eyal Klement, Gilad Segev
openalex +1 more source

